CVE-2023-42435
HIGHCVSS 8.8/10EPSS 0.18%
Last modified
CVE-2023-42435 is a high-severity vulnerability rated 8.8/10 on the CVSS scale. The affected product is vulnerable to a cross-site request forgery vulnerability, which may allow an attacker to perform actions with the permissions of a victim user. . EPSS estimates a 0.18% chance of exploitation in the next 30 days.
Description
The affected product is vulnerable to a cross-site request forgery vulnerability, which may allow an attacker to perform actions with the permissions of a victim user.
Metrics
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Dexma | Dexgate | 20130114 |
References
- https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02Third Party Advisory, US Government Resource
- https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02Third Party Advisory, US Government Resource
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2023-42435?
The affected product is vulnerable to a cross-site request forgery vulnerability, which may allow an attacker to perform actions with the permissions of a victim user.
How severe is CVE-2023-42435?
CVE-2023-42435 has a CVSS score of 8.8/10 (HIGH severity). The EPSS model estimates a 0.18% probability of exploitation in the next 30 days.
How do I fix CVE-2023-42435?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2023-42435?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST